nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Terbutaline—BCHE—breast cancer	0.00469	0.284	CrCbGaD
Pirbuterol—Clenbuterol—TNF—breast cancer	0.00364	0.22	CrCbGaD
Pirbuterol—Clenbuterol—CYP1A1—breast cancer	0.00277	0.167	CrCbGaD
Pirbuterol—Salbutamol—CYP3A4—breast cancer	0.00164	0.0993	CrCbGaD
Pirbuterol—Epinephrine—TNF—breast cancer	0.00153	0.0925	CrCbGaD
Pirbuterol—Nadolol—ABCB1—breast cancer	0.00152	0.0921	CrCbGaD
Pirbuterol—Nausea—Tamoxifen—breast cancer	0.000749	0.000815	CcSEcCtD
Pirbuterol—Fatigue—Gemcitabine—breast cancer	0.000747	0.000813	CcSEcCtD
Pirbuterol—Epinephrine—CYP3A4—breast cancer	0.000742	0.0449	CrCbGaD
Pirbuterol—Decreased appetite—Fluorouracil—breast cancer	0.000741	0.000806	CcSEcCtD
Pirbuterol—Alopecia—Capecitabine—breast cancer	0.000741	0.000806	CcSEcCtD
Pirbuterol—Dry mouth—Paclitaxel—breast cancer	0.00074	0.000805	CcSEcCtD
Pirbuterol—Asthenia—Thiotepa—breast cancer	0.000739	0.000804	CcSEcCtD
Pirbuterol—Diarrhoea—Vinorelbine—breast cancer	0.000738	0.000803	CcSEcCtD
Pirbuterol—Nausea—Melphalan—breast cancer	0.000734	0.000798	CcSEcCtD
Pirbuterol—Feeling abnormal—Mitoxantrone—breast cancer	0.000733	0.000798	CcSEcCtD
Pirbuterol—Feeling abnormal—Irinotecan—breast cancer	0.000733	0.000798	CcSEcCtD
Pirbuterol—Confusional state—Paclitaxel—breast cancer	0.000732	0.000796	CcSEcCtD
Pirbuterol—Back pain—Docetaxel—breast cancer	0.000729	0.000793	CcSEcCtD
Pirbuterol—Pruritus—Thiotepa—breast cancer	0.000729	0.000793	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000728	0.000791	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Irinotecan—breast cancer	0.000728	0.000791	CcSEcCtD
Pirbuterol—Oedema—Paclitaxel—breast cancer	0.000726	0.000789	CcSEcCtD
Pirbuterol—Muscle spasms—Docetaxel—breast cancer	0.000725	0.000788	CcSEcCtD
Pirbuterol—Nausea—Goserelin—breast cancer	0.000716	0.000778	CcSEcCtD
Pirbuterol—Feeling abnormal—Gemcitabine—breast cancer	0.000714	0.000777	CcSEcCtD
Pirbuterol—Shock—Paclitaxel—breast cancer	0.000714	0.000777	CcSEcCtD
Pirbuterol—Dizziness—Vinorelbine—breast cancer	0.000714	0.000776	CcSEcCtD
Pirbuterol—Tachycardia—Paclitaxel—breast cancer	0.000708	0.00077	CcSEcCtD
Pirbuterol—Back pain—Capecitabine—breast cancer	0.000706	0.000768	CcSEcCtD
Pirbuterol—Diarrhoea—Thiotepa—breast cancer	0.000705	0.000767	CcSEcCtD
Pirbuterol—Abdominal pain—Mitoxantrone—breast cancer	0.000703	0.000765	CcSEcCtD
Pirbuterol—Abdominal pain—Irinotecan—breast cancer	0.000703	0.000765	CcSEcCtD
Pirbuterol—Feeling abnormal—Fluorouracil—breast cancer	0.000702	0.000764	CcSEcCtD
Pirbuterol—Muscle spasms—Capecitabine—breast cancer	0.000702	0.000763	CcSEcCtD
Pirbuterol—Drowsiness—Methotrexate—breast cancer	0.000695	0.000756	CcSEcCtD
Pirbuterol—Anorexia—Paclitaxel—breast cancer	0.000692	0.000752	CcSEcCtD
Pirbuterol—Vomiting—Vinorelbine—breast cancer	0.000686	0.000746	CcSEcCtD
Pirbuterol—Tremor—Capecitabine—breast cancer	0.000684	0.000744	CcSEcCtD
Pirbuterol—Dizziness—Thiotepa—breast cancer	0.000681	0.000741	CcSEcCtD
Pirbuterol—Rash—Vinorelbine—breast cancer	0.00068	0.00074	CcSEcCtD
Pirbuterol—Dermatitis—Vinorelbine—breast cancer	0.00068	0.000739	CcSEcCtD
Pirbuterol—Hypotension—Paclitaxel—breast cancer	0.000678	0.000738	CcSEcCtD
Pirbuterol—Stomatitis—Methotrexate—breast cancer	0.000678	0.000737	CcSEcCtD
Pirbuterol—Headache—Vinorelbine—breast cancer	0.000676	0.000735	CcSEcCtD
Pirbuterol—Syncope—Docetaxel—breast cancer	0.000676	0.000735	CcSEcCtD
Pirbuterol—Palpitations—Docetaxel—breast cancer	0.000666	0.000724	CcSEcCtD
Pirbuterol—Weight increased—Epirubicin—breast cancer	0.000664	0.000722	CcSEcCtD
Pirbuterol—Loss of consciousness—Docetaxel—breast cancer	0.000662	0.00072	CcSEcCtD
Pirbuterol—Cough—Docetaxel—breast cancer	0.000658	0.000715	CcSEcCtD
Pirbuterol—Insomnia—Paclitaxel—breast cancer	0.000656	0.000714	CcSEcCtD
Pirbuterol—Vomiting—Thiotepa—breast cancer	0.000655	0.000713	CcSEcCtD
Pirbuterol—Syncope—Capecitabine—breast cancer	0.000654	0.000712	CcSEcCtD
Pirbuterol—Drowsiness—Epirubicin—breast cancer	0.000651	0.000708	CcSEcCtD
Pirbuterol—Rash—Thiotepa—breast cancer	0.00065	0.000707	CcSEcCtD
Pirbuterol—Dermatitis—Thiotepa—breast cancer	0.000649	0.000706	CcSEcCtD
Pirbuterol—Headache—Thiotepa—breast cancer	0.000646	0.000702	CcSEcCtD
Pirbuterol—Somnolence—Paclitaxel—breast cancer	0.000645	0.000702	CcSEcCtD
Pirbuterol—Palpitations—Capecitabine—breast cancer	0.000645	0.000701	CcSEcCtD
Pirbuterol—Chest pain—Docetaxel—breast cancer	0.000642	0.000698	CcSEcCtD
Pirbuterol—Loss of consciousness—Capecitabine—breast cancer	0.000641	0.000698	CcSEcCtD
Pirbuterol—Nausea—Vinorelbine—breast cancer	0.000641	0.000697	CcSEcCtD
Pirbuterol—Asthenia—Irinotecan—breast cancer	0.000638	0.000694	CcSEcCtD
Pirbuterol—Asthenia—Mitoxantrone—breast cancer	0.000638	0.000694	CcSEcCtD
Pirbuterol—Cough—Capecitabine—breast cancer	0.000637	0.000693	CcSEcCtD
Pirbuterol—Stomatitis—Epirubicin—breast cancer	0.000634	0.00069	CcSEcCtD
Pirbuterol—Decreased appetite—Paclitaxel—breast cancer	0.000631	0.000686	CcSEcCtD
Pirbuterol—Dry mouth—Docetaxel—breast cancer	0.000628	0.000683	CcSEcCtD
Pirbuterol—Fatigue—Paclitaxel—breast cancer	0.000626	0.00068	CcSEcCtD
Pirbuterol—Asthenia—Gemcitabine—breast cancer	0.000622	0.000676	CcSEcCtD
Pirbuterol—Chest pain—Capecitabine—breast cancer	0.000621	0.000676	CcSEcCtD
Pirbuterol—Confusional state—Docetaxel—breast cancer	0.00062	0.000675	CcSEcCtD
Pirbuterol—Anxiety—Capecitabine—breast cancer	0.000619	0.000673	CcSEcCtD
Pirbuterol—Oedema—Docetaxel—breast cancer	0.000615	0.000669	CcSEcCtD
Pirbuterol—Weight increased—Doxorubicin—breast cancer	0.000614	0.000668	CcSEcCtD
Pirbuterol—Pruritus—Gemcitabine—breast cancer	0.000613	0.000667	CcSEcCtD
Pirbuterol—Nausea—Thiotepa—breast cancer	0.000612	0.000666	CcSEcCtD
Pirbuterol—Diarrhoea—Mitoxantrone—breast cancer	0.000609	0.000662	CcSEcCtD
Pirbuterol—Diarrhoea—Irinotecan—breast cancer	0.000609	0.000662	CcSEcCtD
Pirbuterol—Dry mouth—Capecitabine—breast cancer	0.000608	0.000661	CcSEcCtD
Pirbuterol—Shock—Docetaxel—breast cancer	0.000605	0.000658	CcSEcCtD
Pirbuterol—Pruritus—Fluorouracil—breast cancer	0.000603	0.000656	CcSEcCtD
Pirbuterol—Drowsiness—Doxorubicin—breast cancer	0.000602	0.000655	CcSEcCtD
Pirbuterol—Confusional state—Capecitabine—breast cancer	0.000601	0.000653	CcSEcCtD
Pirbuterol—Tachycardia—Docetaxel—breast cancer	0.0006	0.000653	CcSEcCtD
Pirbuterol—Feeling abnormal—Paclitaxel—breast cancer	0.000598	0.00065	CcSEcCtD
Pirbuterol—Oedema—Capecitabine—breast cancer	0.000596	0.000648	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Paclitaxel—breast cancer	0.000593	0.000645	CcSEcCtD
Pirbuterol—Diarrhoea—Gemcitabine—breast cancer	0.000593	0.000645	CcSEcCtD
Pirbuterol—Dizziness—Irinotecan—breast cancer	0.000588	0.00064	CcSEcCtD
Pirbuterol—Stomatitis—Doxorubicin—breast cancer	0.000587	0.000638	CcSEcCtD
Pirbuterol—Anorexia—Docetaxel—breast cancer	0.000586	0.000638	CcSEcCtD
Pirbuterol—Shock—Capecitabine—breast cancer	0.000586	0.000637	CcSEcCtD
Pirbuterol—Diarrhoea—Fluorouracil—breast cancer	0.000583	0.000634	CcSEcCtD
Pirbuterol—Tachycardia—Capecitabine—breast cancer	0.000581	0.000632	CcSEcCtD
Pirbuterol—Hypoaesthesia—Epirubicin—breast cancer	0.000581	0.000632	CcSEcCtD
Pirbuterol—Hypotension—Docetaxel—breast cancer	0.000575	0.000625	CcSEcCtD
Pirbuterol—Abdominal pain—Paclitaxel—breast cancer	0.000574	0.000624	CcSEcCtD
Pirbuterol—Anorexia—Capecitabine—breast cancer	0.000568	0.000617	CcSEcCtD
Pirbuterol—Vomiting—Mitoxantrone—breast cancer	0.000566	0.000615	CcSEcCtD
Pirbuterol—Vomiting—Irinotecan—breast cancer	0.000566	0.000615	CcSEcCtD
Pirbuterol—Dizziness—Fluorouracil—breast cancer	0.000564	0.000613	CcSEcCtD
Pirbuterol—Rash—Irinotecan—breast cancer	0.000561	0.00061	CcSEcCtD
Pirbuterol—Rash—Mitoxantrone—breast cancer	0.000561	0.00061	CcSEcCtD
Pirbuterol—Dermatitis—Mitoxantrone—breast cancer	0.000561	0.00061	CcSEcCtD
Pirbuterol—Dermatitis—Irinotecan—breast cancer	0.000561	0.00061	CcSEcCtD
Pirbuterol—Headache—Irinotecan—breast cancer	0.000557	0.000606	CcSEcCtD
Pirbuterol—Headache—Mitoxantrone—breast cancer	0.000557	0.000606	CcSEcCtD
Pirbuterol—Hypotension—Capecitabine—breast cancer	0.000557	0.000605	CcSEcCtD
Pirbuterol—Insomnia—Docetaxel—breast cancer	0.000556	0.000605	CcSEcCtD
Pirbuterol—Alopecia—Methotrexate—breast cancer	0.000551	0.0006	CcSEcCtD
Pirbuterol—Vomiting—Gemcitabine—breast cancer	0.000551	0.000599	CcSEcCtD
Pirbuterol—Somnolence—Docetaxel—breast cancer	0.000547	0.000595	CcSEcCtD
Pirbuterol—Rash—Gemcitabine—breast cancer	0.000547	0.000594	CcSEcCtD
Pirbuterol—Dermatitis—Gemcitabine—breast cancer	0.000546	0.000594	CcSEcCtD
Pirbuterol—Headache—Gemcitabine—breast cancer	0.000543	0.000591	CcSEcCtD
Pirbuterol—Flushing—Epirubicin—breast cancer	0.000542	0.000589	CcSEcCtD
Pirbuterol—Vomiting—Fluorouracil—breast cancer	0.000542	0.000589	CcSEcCtD
Pirbuterol—Insomnia—Capecitabine—breast cancer	0.000539	0.000586	CcSEcCtD
Pirbuterol—Hypoaesthesia—Doxorubicin—breast cancer	0.000538	0.000585	CcSEcCtD
Pirbuterol—Rash—Fluorouracil—breast cancer	0.000537	0.000584	CcSEcCtD
Pirbuterol—Dermatitis—Fluorouracil—breast cancer	0.000537	0.000584	CcSEcCtD
Pirbuterol—Decreased appetite—Docetaxel—breast cancer	0.000535	0.000582	CcSEcCtD
Pirbuterol—Headache—Fluorouracil—breast cancer	0.000534	0.000581	CcSEcCtD
Pirbuterol—Fatigue—Docetaxel—breast cancer	0.00053	0.000577	CcSEcCtD
Pirbuterol—Nausea—Mitoxantrone—breast cancer	0.000529	0.000575	CcSEcCtD
Pirbuterol—Nausea—Irinotecan—breast cancer	0.000529	0.000575	CcSEcCtD
Pirbuterol—Back pain—Methotrexate—breast cancer	0.000525	0.000571	CcSEcCtD
Pirbuterol—Asthenia—Paclitaxel—breast cancer	0.000521	0.000566	CcSEcCtD
Pirbuterol—Decreased appetite—Capecitabine—breast cancer	0.000518	0.000563	CcSEcCtD
Pirbuterol—Alopecia—Epirubicin—breast cancer	0.000516	0.000561	CcSEcCtD
Pirbuterol—Nausea—Gemcitabine—breast cancer	0.000515	0.00056	CcSEcCtD
Pirbuterol—Fatigue—Capecitabine—breast cancer	0.000513	0.000558	CcSEcCtD
Pirbuterol—Pruritus—Paclitaxel—breast cancer	0.000513	0.000558	CcSEcCtD
Pirbuterol—Feeling abnormal—Docetaxel—breast cancer	0.000507	0.000551	CcSEcCtD
Pirbuterol—Nausea—Fluorouracil—breast cancer	0.000506	0.000551	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Docetaxel—breast cancer	0.000503	0.000547	CcSEcCtD
Pirbuterol—Flushing—Doxorubicin—breast cancer	0.000502	0.000545	CcSEcCtD
Pirbuterol—Tension—Epirubicin—breast cancer	0.000499	0.000543	CcSEcCtD
Pirbuterol—Diarrhoea—Paclitaxel—breast cancer	0.000497	0.00054	CcSEcCtD
Pirbuterol—Nervousness—Epirubicin—breast cancer	0.000494	0.000537	CcSEcCtD
Pirbuterol—Back pain—Epirubicin—breast cancer	0.000492	0.000535	CcSEcCtD
Pirbuterol—Feeling abnormal—Capecitabine—breast cancer	0.000491	0.000534	CcSEcCtD
Pirbuterol—Muscle spasms—Epirubicin—breast cancer	0.000489	0.000532	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Capecitabine—breast cancer	0.000487	0.00053	CcSEcCtD
Pirbuterol—Abdominal pain—Docetaxel—breast cancer	0.000486	0.000529	CcSEcCtD
Pirbuterol—Dizziness—Paclitaxel—breast cancer	0.00048	0.000522	CcSEcCtD
Pirbuterol—Alopecia—Doxorubicin—breast cancer	0.000478	0.000519	CcSEcCtD
Pirbuterol—Cough—Methotrexate—breast cancer	0.000474	0.000516	CcSEcCtD
Pirbuterol—Abdominal pain—Capecitabine—breast cancer	0.000471	0.000512	CcSEcCtD
Pirbuterol—Agitation—Epirubicin—breast cancer	0.000467	0.000508	CcSEcCtD
Pirbuterol—Chest pain—Methotrexate—breast cancer	0.000462	0.000503	CcSEcCtD
Pirbuterol—Tension—Doxorubicin—breast cancer	0.000462	0.000502	CcSEcCtD
Pirbuterol—Vomiting—Paclitaxel—breast cancer	0.000461	0.000502	CcSEcCtD
Pirbuterol—Rash—Paclitaxel—breast cancer	0.000458	0.000498	CcSEcCtD
Pirbuterol—Dermatitis—Paclitaxel—breast cancer	0.000457	0.000497	CcSEcCtD
Pirbuterol—Nervousness—Doxorubicin—breast cancer	0.000457	0.000497	CcSEcCtD
Pirbuterol—Syncope—Epirubicin—breast cancer	0.000456	0.000496	CcSEcCtD
Pirbuterol—Back pain—Doxorubicin—breast cancer	0.000455	0.000495	CcSEcCtD
Pirbuterol—Headache—Paclitaxel—breast cancer	0.000455	0.000494	CcSEcCtD
Pirbuterol—Muscle spasms—Doxorubicin—breast cancer	0.000452	0.000492	CcSEcCtD
Pirbuterol—Palpitations—Epirubicin—breast cancer	0.000449	0.000489	CcSEcCtD
Pirbuterol—Confusional state—Methotrexate—breast cancer	0.000447	0.000486	CcSEcCtD
Pirbuterol—Loss of consciousness—Epirubicin—breast cancer	0.000447	0.000486	CcSEcCtD
Pirbuterol—Cough—Epirubicin—breast cancer	0.000444	0.000482	CcSEcCtD
Pirbuterol—Asthenia—Docetaxel—breast cancer	0.000441	0.00048	CcSEcCtD
Pirbuterol—Pruritus—Docetaxel—breast cancer	0.000435	0.000473	CcSEcCtD
Pirbuterol—Chest pain—Epirubicin—breast cancer	0.000433	0.000471	CcSEcCtD
Pirbuterol—Agitation—Doxorubicin—breast cancer	0.000432	0.00047	CcSEcCtD
Pirbuterol—Anxiety—Epirubicin—breast cancer	0.000431	0.000469	CcSEcCtD
Pirbuterol—Nausea—Paclitaxel—breast cancer	0.000431	0.000469	CcSEcCtD
Pirbuterol—Asthenia—Capecitabine—breast cancer	0.000427	0.000465	CcSEcCtD
Pirbuterol—Dry mouth—Epirubicin—breast cancer	0.000423	0.00046	CcSEcCtD
Pirbuterol—Anorexia—Methotrexate—breast cancer	0.000423	0.00046	CcSEcCtD
Pirbuterol—Syncope—Doxorubicin—breast cancer	0.000422	0.000459	CcSEcCtD
Pirbuterol—Pruritus—Capecitabine—breast cancer	0.000421	0.000458	CcSEcCtD
Pirbuterol—Diarrhoea—Docetaxel—breast cancer	0.000421	0.000458	CcSEcCtD
Pirbuterol—Confusional state—Epirubicin—breast cancer	0.000418	0.000455	CcSEcCtD
Pirbuterol—Palpitations—Doxorubicin—breast cancer	0.000416	0.000452	CcSEcCtD
Pirbuterol—Oedema—Epirubicin—breast cancer	0.000415	0.000451	CcSEcCtD
Pirbuterol—Hypotension—Methotrexate—breast cancer	0.000414	0.000451	CcSEcCtD
Pirbuterol—Loss of consciousness—Doxorubicin—breast cancer	0.000413	0.00045	CcSEcCtD
Pirbuterol—Cough—Doxorubicin—breast cancer	0.00041	0.000446	CcSEcCtD
Pirbuterol—Shock—Epirubicin—breast cancer	0.000408	0.000444	CcSEcCtD
Pirbuterol—Diarrhoea—Capecitabine—breast cancer	0.000408	0.000443	CcSEcCtD
Pirbuterol—Dizziness—Docetaxel—breast cancer	0.000407	0.000442	CcSEcCtD
Pirbuterol—Tachycardia—Epirubicin—breast cancer	0.000405	0.00044	CcSEcCtD
Pirbuterol—Insomnia—Methotrexate—breast cancer	0.000401	0.000436	CcSEcCtD
Pirbuterol—Chest pain—Doxorubicin—breast cancer	0.0004	0.000436	CcSEcCtD
Pirbuterol—Anxiety—Doxorubicin—breast cancer	0.000399	0.000434	CcSEcCtD
Pirbuterol—Anorexia—Epirubicin—breast cancer	0.000396	0.00043	CcSEcCtD
Pirbuterol—Somnolence—Methotrexate—breast cancer	0.000394	0.000429	CcSEcCtD
Pirbuterol—Dizziness—Capecitabine—breast cancer	0.000394	0.000428	CcSEcCtD
Pirbuterol—Dry mouth—Doxorubicin—breast cancer	0.000392	0.000426	CcSEcCtD
Pirbuterol—Vomiting—Docetaxel—breast cancer	0.000391	0.000425	CcSEcCtD
Pirbuterol—Rash—Docetaxel—breast cancer	0.000388	0.000422	CcSEcCtD
Pirbuterol—Hypotension—Epirubicin—breast cancer	0.000388	0.000422	CcSEcCtD
Pirbuterol—Dermatitis—Docetaxel—breast cancer	0.000388	0.000421	CcSEcCtD
Pirbuterol—Confusional state—Doxorubicin—breast cancer	0.000387	0.000421	CcSEcCtD
Pirbuterol—Decreased appetite—Methotrexate—breast cancer	0.000385	0.000419	CcSEcCtD
Pirbuterol—Headache—Docetaxel—breast cancer	0.000385	0.000419	CcSEcCtD
Pirbuterol—Oedema—Doxorubicin—breast cancer	0.000384	0.000418	CcSEcCtD
Pirbuterol—Fatigue—Methotrexate—breast cancer	0.000382	0.000416	CcSEcCtD
Pirbuterol—Vomiting—Capecitabine—breast cancer	0.000379	0.000412	CcSEcCtD
Pirbuterol—Shock—Doxorubicin—breast cancer	0.000378	0.000411	CcSEcCtD
Pirbuterol—Rash—Capecitabine—breast cancer	0.000376	0.000408	CcSEcCtD
Pirbuterol—Insomnia—Epirubicin—breast cancer	0.000375	0.000408	CcSEcCtD
Pirbuterol—Dermatitis—Capecitabine—breast cancer	0.000375	0.000408	CcSEcCtD
Pirbuterol—Tachycardia—Doxorubicin—breast cancer	0.000375	0.000407	CcSEcCtD
Pirbuterol—Headache—Capecitabine—breast cancer	0.000373	0.000406	CcSEcCtD
Pirbuterol—Somnolence—Epirubicin—breast cancer	0.000369	0.000401	CcSEcCtD
Pirbuterol—Anorexia—Doxorubicin—breast cancer	0.000366	0.000398	CcSEcCtD
Pirbuterol—Nausea—Docetaxel—breast cancer	0.000365	0.000397	CcSEcCtD
Pirbuterol—Feeling abnormal—Methotrexate—breast cancer	0.000365	0.000397	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Methotrexate—breast cancer	0.000363	0.000394	CcSEcCtD
Pirbuterol—Decreased appetite—Epirubicin—breast cancer	0.000361	0.000392	CcSEcCtD
Pirbuterol—Hypotension—Doxorubicin—breast cancer	0.000359	0.00039	CcSEcCtD
Pirbuterol—Fatigue—Epirubicin—breast cancer	0.000358	0.000389	CcSEcCtD
Pirbuterol—Nausea—Capecitabine—breast cancer	0.000354	0.000385	CcSEcCtD
Pirbuterol—Abdominal pain—Methotrexate—breast cancer	0.00035	0.000381	CcSEcCtD
Pirbuterol—Insomnia—Doxorubicin—breast cancer	0.000347	0.000378	CcSEcCtD
Pirbuterol—Feeling abnormal—Epirubicin—breast cancer	0.000342	0.000372	CcSEcCtD
Pirbuterol—Somnolence—Doxorubicin—breast cancer	0.000341	0.000371	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Epirubicin—breast cancer	0.000339	0.000369	CcSEcCtD
Pirbuterol—Decreased appetite—Doxorubicin—breast cancer	0.000334	0.000363	CcSEcCtD
Pirbuterol—Fatigue—Doxorubicin—breast cancer	0.000331	0.00036	CcSEcCtD
Pirbuterol—Abdominal pain—Epirubicin—breast cancer	0.000328	0.000357	CcSEcCtD
Pirbuterol—Asthenia—Methotrexate—breast cancer	0.000318	0.000346	CcSEcCtD
Pirbuterol—Feeling abnormal—Doxorubicin—breast cancer	0.000316	0.000344	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Doxorubicin—breast cancer	0.000314	0.000341	CcSEcCtD
Pirbuterol—Pruritus—Methotrexate—breast cancer	0.000314	0.000341	CcSEcCtD
Pirbuterol—Abdominal pain—Doxorubicin—breast cancer	0.000303	0.00033	CcSEcCtD
Pirbuterol—Diarrhoea—Methotrexate—breast cancer	0.000303	0.00033	CcSEcCtD
Pirbuterol—Asthenia—Epirubicin—breast cancer	0.000298	0.000324	CcSEcCtD
Pirbuterol—Pruritus—Epirubicin—breast cancer	0.000294	0.000319	CcSEcCtD
Pirbuterol—Dizziness—Methotrexate—breast cancer	0.000293	0.000319	CcSEcCtD
Pirbuterol—Diarrhoea—Epirubicin—breast cancer	0.000284	0.000309	CcSEcCtD
Pirbuterol—Vomiting—Methotrexate—breast cancer	0.000282	0.000307	CcSEcCtD
Pirbuterol—Rash—Methotrexate—breast cancer	0.00028	0.000304	CcSEcCtD
Pirbuterol—Dermatitis—Methotrexate—breast cancer	0.000279	0.000304	CcSEcCtD
Pirbuterol—Headache—Methotrexate—breast cancer	0.000278	0.000302	CcSEcCtD
Pirbuterol—Asthenia—Doxorubicin—breast cancer	0.000275	0.0003	CcSEcCtD
Pirbuterol—Dizziness—Epirubicin—breast cancer	0.000274	0.000298	CcSEcCtD
Pirbuterol—Pruritus—Doxorubicin—breast cancer	0.000272	0.000295	CcSEcCtD
Pirbuterol—Vomiting—Epirubicin—breast cancer	0.000264	0.000287	CcSEcCtD
Pirbuterol—Nausea—Methotrexate—breast cancer	0.000263	0.000286	CcSEcCtD
Pirbuterol—Diarrhoea—Doxorubicin—breast cancer	0.000263	0.000286	CcSEcCtD
Pirbuterol—Rash—Epirubicin—breast cancer	0.000262	0.000285	CcSEcCtD
Pirbuterol—Dermatitis—Epirubicin—breast cancer	0.000261	0.000284	CcSEcCtD
Pirbuterol—Headache—Epirubicin—breast cancer	0.00026	0.000283	CcSEcCtD
Pirbuterol—Dizziness—Doxorubicin—breast cancer	0.000254	0.000276	CcSEcCtD
Pirbuterol—Nausea—Epirubicin—breast cancer	0.000246	0.000268	CcSEcCtD
Pirbuterol—Vomiting—Doxorubicin—breast cancer	0.000244	0.000265	CcSEcCtD
Pirbuterol—Rash—Doxorubicin—breast cancer	0.000242	0.000263	CcSEcCtD
Pirbuterol—Dermatitis—Doxorubicin—breast cancer	0.000242	0.000263	CcSEcCtD
Pirbuterol—Headache—Doxorubicin—breast cancer	0.000241	0.000262	CcSEcCtD
Pirbuterol—Nausea—Doxorubicin—breast cancer	0.000228	0.000248	CcSEcCtD
Pirbuterol—ADRB2—Signaling Pathways—VEGFC—breast cancer	4.66e-05	0.000729	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—WNT1—breast cancer	4.62e-05	0.000723	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PLA2G4A—breast cancer	4.61e-05	0.000721	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAG2—breast cancer	4.59e-05	0.000718	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CSF2—breast cancer	4.56e-05	0.000713	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—WNT1—breast cancer	4.52e-05	0.000707	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PLA2G4A—breast cancer	4.51e-05	0.000706	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CSF2—breast cancer	4.46e-05	0.000698	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH4—breast cancer	4.38e-05	0.000685	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GZMB—breast cancer	4.36e-05	0.000681	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH4—breast cancer	4.29e-05	0.00067	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GZMB—breast cancer	4.26e-05	0.000666	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGTR2—breast cancer	4.23e-05	0.000661	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL2—breast cancer	4.23e-05	0.000661	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTHLH—breast cancer	4.18e-05	0.000654	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—BMP2—breast cancer	4.18e-05	0.000654	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGTR2—breast cancer	4.14e-05	0.000647	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL2—breast cancer	4.14e-05	0.000647	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—BMP2—breast cancer	4.09e-05	0.00064	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTHLH—breast cancer	4.09e-05	0.00064	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EDNRB—breast cancer	4.05e-05	0.000633	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PGR—breast cancer	4.01e-05	0.000627	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—THBS1—breast cancer	3.99e-05	0.000624	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EDNRB—breast cancer	3.96e-05	0.000619	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PGR—breast cancer	3.92e-05	0.000613	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—THBS1—breast cancer	3.9e-05	0.00061	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FLT1—breast cancer	3.81e-05	0.000595	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF3—breast cancer	3.79e-05	0.000593	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SQSTM1—breast cancer	3.79e-05	0.000593	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CG—breast cancer	3.77e-05	0.00059	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JAG1—breast cancer	3.74e-05	0.000585	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PARP1—breast cancer	3.73e-05	0.000583	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH3—breast cancer	3.73e-05	0.000583	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FLT1—breast cancer	3.73e-05	0.000582	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF3—breast cancer	3.71e-05	0.00058	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SQSTM1—breast cancer	3.71e-05	0.00058	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CG—breast cancer	3.69e-05	0.000577	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CALCA—breast cancer	3.68e-05	0.000576	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAG1—breast cancer	3.66e-05	0.000572	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PARP1—breast cancer	3.65e-05	0.00057	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH3—breast cancer	3.65e-05	0.00057	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RPS6—breast cancer	3.64e-05	0.000569	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF4—breast cancer	3.61e-05	0.000564	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CALCA—breast cancer	3.6e-05	0.000563	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCR4—breast cancer	3.6e-05	0.000562	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL12—breast cancer	3.6e-05	0.000562	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RPS6—breast cancer	3.56e-05	0.000556	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF4—breast cancer	3.53e-05	0.000552	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PAK1—breast cancer	3.53e-05	0.000552	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCR4—breast cancer	3.52e-05	0.00055	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL12—breast cancer	3.52e-05	0.00055	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TCF7L2—breast cancer	3.47e-05	0.000542	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PAK1—breast cancer	3.45e-05	0.00054	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT2—breast cancer	3.45e-05	0.00054	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CG—breast cancer	3.43e-05	0.000536	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TCF7L2—breast cancer	3.39e-05	0.00053	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT2—breast cancer	3.38e-05	0.000528	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	3.35e-05	0.000524	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	3.34e-05	0.000523	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH2—breast cancer	3.34e-05	0.000523	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	3.32e-05	0.000518	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	3.27e-05	0.000511	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH2—breast cancer	3.27e-05	0.000511	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRL—breast cancer	3.25e-05	0.000508	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGTR1—breast cancer	3.25e-05	0.000508	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	3.24e-05	0.000507	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STK11—breast cancer	3.21e-05	0.000501	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADAM10—breast cancer	3.21e-05	0.000501	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRL—breast cancer	3.18e-05	0.000497	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGTR1—breast cancer	3.18e-05	0.000497	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLG—breast cancer	3.17e-05	0.000496	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STK11—breast cancer	3.14e-05	0.00049	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADAM10—breast cancer	3.14e-05	0.00049	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT2—breast cancer	3.13e-05	0.00049	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF10—breast cancer	3.12e-05	0.000487	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLG—breast cancer	3.1e-05	0.000485	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT2—breast cancer	3.07e-05	0.000479	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF10—breast cancer	3.05e-05	0.000477	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	3.01e-05	0.000471	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFA—breast cancer	3.01e-05	0.00047	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	2.97e-05	0.000464	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	2.95e-05	0.000461	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFA—breast cancer	2.94e-05	0.00046	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ITPR1—breast cancer	2.92e-05	0.000456	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	2.9e-05	0.000454	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT5A—breast cancer	2.9e-05	0.000453	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP3—breast cancer	2.9e-05	0.000453	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ERBB4—breast cancer	2.9e-05	0.000453	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	2.89e-05	0.000452	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ITPR1—breast cancer	2.86e-05	0.000446	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT5A—breast cancer	2.84e-05	0.000443	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP3—breast cancer	2.84e-05	0.000443	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ERBB4—breast cancer	2.84e-05	0.000443	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	2.83e-05	0.000442	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SMAD4—breast cancer	2.81e-05	0.000439	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1R—breast cancer	2.79e-05	0.000436	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	2.78e-05	0.000434	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SMAD4—breast cancer	2.75e-05	0.000429	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HES1—breast cancer	2.74e-05	0.000429	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1R—breast cancer	2.73e-05	0.000427	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NCOR1—breast cancer	2.73e-05	0.000426	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	2.73e-05	0.000426	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	2.72e-05	0.000425	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CSF2—breast cancer	2.7e-05	0.000421	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF1—breast cancer	2.7e-05	0.000421	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—RAF1—breast cancer	2.69e-05	0.00042	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HES1—breast cancer	2.68e-05	0.000419	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NRG1—breast cancer	2.68e-05	0.000418	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	2.67e-05	0.000417	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NCOR1—breast cancer	2.67e-05	0.000417	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—H2AFX—breast cancer	2.66e-05	0.000415	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—IL2—breast cancer	2.66e-05	0.000415	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—E2F1—breast cancer	2.64e-05	0.000412	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF1—breast cancer	2.64e-05	0.000412	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CSF2—breast cancer	2.64e-05	0.000412	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—RAF1—breast cancer	2.63e-05	0.000411	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	2.63e-05	0.00041	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NRG1—breast cancer	2.62e-05	0.000409	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—H2AFX—breast cancer	2.6e-05	0.000406	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—IL2—breast cancer	2.6e-05	0.000406	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—E2F1—breast cancer	2.58e-05	0.000403	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	2.57e-05	0.000401	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SPP1—breast cancer	2.53e-05	0.000396	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	2.52e-05	0.000394	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ERBB3—breast cancer	2.51e-05	0.000392	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGFR2—breast cancer	2.5e-05	0.000391	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SPP1—breast cancer	2.48e-05	0.000388	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	2.47e-05	0.000386	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ERBB3—breast cancer	2.45e-05	0.000383	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGFR2—breast cancer	2.45e-05	0.000383	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL2—breast cancer	2.41e-05	0.000377	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TERT—breast cancer	2.4e-05	0.000376	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL2—breast cancer	2.36e-05	0.000369	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TERT—breast cancer	2.35e-05	0.000367	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGFR1—breast cancer	2.33e-05	0.000365	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HIF1A—breast cancer	2.3e-05	0.000359	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGFR1—breast cancer	2.28e-05	0.000357	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HIF1A—breast cancer	2.25e-05	0.000351	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LEP—breast cancer	2.24e-05	0.000351	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CAV1—breast cancer	2.22e-05	0.000347	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KDR—breast cancer	2.2e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LEP—breast cancer	2.19e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CAV1—breast cancer	2.17e-05	0.00034	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KDR—breast cancer	2.15e-05	0.000336	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ESR1—breast cancer	2.14e-05	0.000335	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FN1—breast cancer	2.11e-05	0.000331	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ESR1—breast cancer	2.09e-05	0.000327	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	2.09e-05	0.000327	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	2.07e-05	0.000324	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FN1—breast cancer	2.07e-05	0.000323	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	2.04e-05	0.00032	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	2.02e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	2.02e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KIT—breast cancer	2.02e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APC—breast cancer	2.02e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGF—breast cancer	2e-05	0.000313	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	1.98e-05	0.00031	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APC—breast cancer	1.98e-05	0.00031	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KIT—breast cancer	1.98e-05	0.00031	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGF—breast cancer	1.96e-05	0.000306	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	1.94e-05	0.000303	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—BRAF—breast cancer	1.9e-05	0.000297	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	1.9e-05	0.000296	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—BRAF—breast cancer	1.86e-05	0.000291	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1—breast cancer	1.85e-05	0.00029	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT2—breast cancer	1.85e-05	0.000289	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EGFR—breast cancer	1.84e-05	0.000288	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1—breast cancer	1.81e-05	0.000283	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT2—breast cancer	1.81e-05	0.000283	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EGFR—breast cancer	1.8e-05	0.000282	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	1.78e-05	0.000278	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	1.76e-05	0.000276	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	1.76e-05	0.000275	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—KRAS—breast cancer	1.74e-05	0.000272	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	1.74e-05	0.000272	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	1.72e-05	0.00027	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	1.72e-05	0.000269	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—KRAS—breast cancer	1.7e-05	0.000266	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOS3—breast cancer	1.68e-05	0.000263	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOS3—breast cancer	1.64e-05	0.000257	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	1.6e-05	0.00025	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MDM2—breast cancer	1.59e-05	0.000249	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RAF1—breast cancer	1.59e-05	0.000248	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RELA—breast cancer	1.58e-05	0.000247	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ERBB2—breast cancer	1.57e-05	0.000246	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	1.57e-05	0.000245	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MDM2—breast cancer	1.56e-05	0.000244	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RAF1—breast cancer	1.55e-05	0.000243	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MTOR—breast cancer	1.55e-05	0.000242	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	1.55e-05	0.000242	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RELA—breast cancer	1.55e-05	0.000242	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ERBB2—breast cancer	1.54e-05	0.00024	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MTOR—breast cancer	1.52e-05	0.000237	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	1.52e-05	0.000237	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.49e-05	0.000233	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.48e-05	0.000231	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL8—breast cancer	1.46e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.46e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—HRAS—breast cancer	1.45e-05	0.000226	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.44e-05	0.000225	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASP3—breast cancer	1.43e-05	0.000223	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL2—breast cancer	1.42e-05	0.000223	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	1.42e-05	0.000223	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6—breast cancer	1.42e-05	0.000222	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	1.41e-05	0.00022	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASP3—breast cancer	1.4e-05	0.000218	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL2—breast cancer	1.39e-05	0.000218	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCND1—breast cancer	1.39e-05	0.000217	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6—breast cancer	1.39e-05	0.000217	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JUN—breast cancer	1.39e-05	0.000217	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.37e-05	0.000215	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCND1—breast cancer	1.36e-05	0.000212	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JUN—breast cancer	1.36e-05	0.000212	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP9—breast cancer	1.35e-05	0.000211	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	1.35e-05	0.00021	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.34e-05	0.00021	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTEN—breast cancer	1.34e-05	0.000209	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP9—breast cancer	1.32e-05	0.000206	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.31e-05	0.000205	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.31e-05	0.000205	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTEN—breast cancer	1.31e-05	0.000205	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.31e-05	0.000204	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.28e-05	0.0002	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.28e-05	0.0002	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SRC—breast cancer	1.24e-05	0.000194	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SRC—breast cancer	1.22e-05	0.00019	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.21e-05	0.000189	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT3—breast cancer	1.2e-05	0.000187	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.18e-05	0.000185	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT3—breast cancer	1.17e-05	0.000183	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.15e-05	0.000179	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK3—breast cancer	1.12e-05	0.000175	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MYC—breast cancer	1.11e-05	0.000174	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.11e-05	0.000174	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MYC—breast cancer	1.09e-05	0.00017	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGFR—breast cancer	1.09e-05	0.00017	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—breast cancer	1.09e-05	0.00017	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGFR—breast cancer	1.07e-05	0.000167	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KRAS—breast cancer	1.03e-05	0.000161	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KRAS—breast cancer	1.01e-05	0.000157	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	9.45e-06	0.000148	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	9.25e-06	0.000145	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TP53—breast cancer	9.15e-06	0.000143	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TP53—breast cancer	8.95e-06	0.00014	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HRAS—breast cancer	8.75e-06	0.000137	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HRAS—breast cancer	8.56e-06	0.000134	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6—breast cancer	8.37e-06	0.000131	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6—breast cancer	8.19e-06	0.000128	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—breast cancer	7.72e-06	0.000121	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—breast cancer	7.56e-06	0.000118	CbGpPWpGaD
